Separation Systems for Commercial Biotechnology Market Size & Forecast Report, 2014 - 2025

Global Separation Systems for Commercial Biotechnology Market size is expected to reach USD 39.47 billion by 2025. The separation systems in biotechnology are also termed “bioseparation systems”. Bioseparation systems are used for the purification and separation of biological products such as biopharmaceuticals, biochemicals, and diagnostic reagents depending upon the electrostatic charge, density, diffusivity, shape, polarity, solubility, and volatility characteristics. The equipment used for the separation of biological material from complex mixture or solution includes chromatography, membrane/ filters, and centrifuges. The separation systems for the commercial biotechnology industry are expected to grow at the highest CAGR over the forecast period as the scope, product types, and applications are increasing across the world.

The factors that play an important role in the growth of separation systems for the commercial biotechnology market include increasing demand for novel drug molecules & cell-based therapies, booming biopharmaceutical & biotech firms, technological advancements in the biotechnology sector, and stringent government rules & regulations. However, the high cost of bioseparation equipment and strict regulations regarding bioseparation systems are negatively affecting the growth of the market. The separation systems for the commercial biotechnology industry are categorized based on method, application, and geography.

Methods that could be explored in separation systems for the commercial biotechnology market include conventional methods and modern methods. The conventional methods are classified into flow cytometry, chromatography, membrane filtration, centrifugation, electrophoresis, and others while the “modern methods” are segmented into lab-on-a-chip, microarray, biochip, magnetic separation, and others. Conventional methods are expected to hold the largest market share in the forthcoming years. High investment by industrial key players for innovation of enhanced techniques such as membrane filtration and flow cytometry systems are factors driving the growth of conventional methods in the future period. However, modern methods are anticipated to grow at the fastest pace in the years to come due to the rising adoption of enhanced technology and increasing ongoing inventions in the biotechnology field.

Applications such as pharmaceutical, agriculture, food & cosmetics, energy, life sciences research, and others could be explored in separation systems for the commercial biotechnology industry in the coming years. Pharmaceutical is expected to be the largest application due to the rising demand for biotherapies and ongoing inventions in the field of novel drug molecules.

North America is expected to be the top market for separation systems for commercial biotechnology in the future period. The presence of key manufacturers, growing technological advancements, and continuous R&D are anticipated to drive the market in this region in the upcoming period. The U.S. represents the largest market for bioseparation systems in North America, followed by Canada. Further Europe and the Asia Pacific follow the market.

On the other hand, the Asia Pacific market is projected to hold a higher share in the separation systems for the commercial biotechnology market in the forecast period. As increasing R&D expenditure and government initiative for the development of separation system in emerging countries such as India & China. Also, the shortage of vaccines across the world, high demand for therapeutics, and ongoing research in the biotechnology field are expected to boost the market growth in this region.

The key players operating in the separation systems for commercial biotechnology industry are Shimadzu Corporation, MiltenyiBiotec, PerkinElmerInc., GE Healthcare, Agilent Technologies, Bio-Rad LaboratoriesInc., Thermo Fisher Scientific, Merck & Co.Inc., bioMérieux SA, Hitachi Koki Co.Ltd., WATERS, Sartorius, QIAGEN, Danaher and BD. These market players strongly invest in the expansion of their business and the development of new biotechnologies systems to maintain a top position in the market. Also, these players concentrate on new joint ventures, collaborations, agreements, and strategies to improve their production facilities and gain a larger share in the market.

Market Segment:

Method Outlook (Revenue, USD Million; 2014 - 2025)
    • Modern methods
        • Microarray
        • Lab-on-a-chip
        • Biochip
        • Magnetic separation
    • Conventional methods
        • Chromatography
        • Flow cytometry
        • Membrane filtration
        • Electrophoresis
        • Centrifugation

Application Outlook (Revenue, USD Million; 2014 - 2025)
    • Pharmaceutical
        • Vaccines
        • Proteins
        • Hormones/Insulin
        • Enzymes
        • Human Blood Plasma Fractionation
        • Mammalian Cell Cultures
    • Food & Cosmetics
    • Agriculture
    • Others

Regional Outlook (Revenue, USD Million; 2014 - 2025)
    • North America
        • the U.S.
        • Canada
    • Europe
        • Germany
        • the UK
    • the Asia Pacific
        • China
        • India
    • Latin America
        • Brazil
    • the Middle East and Africa (MEA)
        • South Africa